India’s Vaccines Industry Can Grow from US$ 2 Billion Up to US$ 5 Billion by 2026: Report
According to a report released on Monday by global consulting firm Kearney in collaboration with the Confederation of Indian Industry (CII), India’s vaccines industry could grow from US$ 2 billion to US$ 4 billion or even US$ 5 billion as new Indian and global pharmaceutical companies include vaccines as a key part of their portfolios.